Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05726279 · ClinicalTrials.gov registry record · NA
PROtecting Maternal Brains From Injury and Stroke
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT05726279 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 26 participants.
The verdict
NCT05726279, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to test a new approach to blood pressure management in postpartum preeclampsia. There will be two groups of patients in this early stage single center trial. Both groups of study participants (observational and interventional) will be treated with standard blood pressure medications while undergoing continuous non-invasive blood pressure and near infrared spectroscopy (NIRS) monitoring for 24 hours. The interventional group will have personalized blood pressure targets according to results of NIRS monitoring which will be updated in real time.
Interventions
- DEVICE NIRS based personalized blood pressure management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05726279
The ClinicalTrials.gov registry entry for NCT05726279 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NIRS based personalized blood pressure management is the first listed.
NCT05726279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05726279 about?
NCT05726279 is a clinical study titled "PROtecting Maternal Brains From Injury and Stroke". The purpose of this study is to test a new approach to blood pressure management in postpartum preeclampsia. There will be two groups of patients in this early stage single center trial. Both groups of study participants (observational and interventional) will be treated with standard blood pressure...
What is the current status of trial NCT05726279?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2023-05-04. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT05726279?
The interventions under investigation include: NIRS based personalized blood pressure management (DEVICE).
Who is sponsoring clinical trial NCT05726279?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.